N/A N=56 The Effect of Jazz on Postoperative Pain and Stress in Patients Undergoing Elective Hysterectomy
Pain · Anxiety
Primary: Change in Heart Rate From Baseline on Arrival in PACU — -3.39; -5.11; -4.18; -4.71 beats per minute
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=38 Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs
Migraine
Primary: Correlation Between Phonophobia (Sound Sensitivity) and Allodynia (Skin Sensitivity) in Subjects With Episodic Migraine — 27; 6 participants — p=0.59
Phase 3 N=416 Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
Intraocular Lens Replacement
Primary: Mean Area Under the Curve Analysis of Change-from-Baseline in Pupil Diameter (mm) During Surgery — 0.1; -0.5 mm — p=0.0001
Phase 2 N=20 Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
Pancreatic Cancer
Primary: Rate of Local Control — 15 participants
N/A N=59 Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
Adult Acute Lymphoblastic Leukemia · Childhood Acute Lymphoblastic Leukemia
Primary: Percentage of Participants With Trough Serum Asparaginase Activity ≥ 0.1 IU/mL — 94.5 Percent of participants
N/A N=78 Completion of OST - a Prospective Study
Opioid Dependence
Primary: Completion of OST — 9 participants
Phase 2 N=20 Breakthrough Dyspnea Fentanyl Study in Cancer Patients
Advanced Cancers · Dyspnea
Primary: Retention Rate — 100; 100 percentage of participants
N/A N=514 Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
Dyslipidemias · Hypercholesterolemia · Hypertriglyceridemia
Primary: Total Cholesterol (TC) Levels at First Acute Coronary Event — 163.5 mg/dL
N/A N=452 Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations
Coronary Artery Disease
Primary: Number of Participants With Appropriate Adherence/ Medication Possession Ratio (MPR) — 137; 105 participants — p=<0.01
N/A N=227 A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
Bronchiolitis
Primary: Length of Stay in the Study-LOS--Intention to Treat Analysis — 2.1; 2.1 Days — p=0.73
Phase 1 N=12 A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg
Depression · Depressive State · Enuresis
Primary: AUClast and AUCinf — 91.35; 260.68; 109.74; 296.87 ng*hr/mL
Phase 2 N=102 Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Prostate Cancer
Primary: PSA of <_ 0.05 ng/ml After Radical Prostatectomy or Radiation Therapy and PSA <_ 2.0 ng/ml for Patients With Clinical Metastases Without Prior Definitive Therapy — 9…
Phase 3 N=390 SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
Binge Eating Disorder
Primary: Change From Baseline in the Number of Binge Days Per Week at Visit 8 Which Spans Weeks 11/12 — -2.26; -3.92 Binge days per week — p=<0.001
Phase 4 N=22 Duloxetine for Menopausal Depression
Depression · Menopause · Vasomotor Symptoms
Primary: Change in Depression Scores as Measured by the Hamilton Rating Scale for Depression — -7.5 units on a scale
Phase 3 N=300 The Kiva® System as a Vertebral Augmentation Treatment
Spinal Fractures · Fractures, Compression · Back Injuries
Primary: Proportion of Participants With Study Success — 120; 123 participants